Heart Health Device Expands to More Pharmacies

A retail rollout of the FDA-cleared KardiaMobile device gives consumers more options for tracking heart rhythms at home.

Updated on Oct. 29, 2026 in Heart Disease

Bold vector editorial illustration of a minimalist heart sensor on a wooden table, representing accessible home heart-rhythm technology. — AliveCor is expanding the retail presence of its KardiaMobile EKG device to Cencora and Good Neighbor Pharmacies to improve cardiovascular screening access. AI Illustration. Upload story photo >

Live Poll

Do you believe at-home health monitoring tools like KardiaMobile improve your ability to manage your health?

AliveCor is rolling out new retail packaging for its FDA-cleared KardiaMobile EKG device to help consumers identify heart health risks. The device, which detects three common arrhythmias, will be available in Cencora and Good Neighbor Pharmacies starting this fall.

Why it matters

With 48% of U.S. adults living with cardiovascular disease and an average wait time of 33 days for cardiology appointments, accessible home screening tools may offer a bridge to faster medical evaluation.

The KardiaMobile device is an FDA-cleared monitor capable of detecting three common arrhythmias in 30 seconds. While it provides medical-grade results, its efficacy in long-term outcomes remains under investigation.

The players

AliveCor

A developer of FDA-cleared personal EKG technology designed for monitoring cardiovascular health.

Cencora

A global pharmaceutical solutions organization that provides distribution and pharmacy services.

Good Neighbor Pharmacy

A network of independent community pharmacies that provides local health access and medication management.

The details

The device works by having users place their fingers on the KardiaMobile sensor for 30 seconds to capture an EKG reading. This electrical activity is processed to identify potential heart rhythm irregularities that may warrant follow-up with a physician. The new packaging serves as a tool to educate shoppers on how this technology detects heart rhythm issues at home.

• October 2026: The new packaging begins rolling out nationwide.
• Fall 2026: The device launches at Cencora and Good Neighbor Pharmacies.

Health Landscape

The retail rollout of the KardiaMobile device reflects a broader trend toward decentralizing heart health monitoring. This approach aims to address gaps in care access by moving diagnostic capabilities into the consumer health space.

If you are concerned about your heart rhythm, this device offers a potential way to capture data between regular checkups. Any findings detected by a home monitor should be discussed with your physician to determine if further testing or clinical evaluation is necessary.

The takeaway

Accessing medical-grade heart data at home can help you identify potential arrhythmias, but it does not replace a formal clinical diagnosis. When using personal screening devices, be sure to keep a log of any flagged readings to review with your doctor during your next visit.